Tvardi Therapeutics, Inc. SEC filings TVRD

Tvardi Therapeutics, Inc. has 809 filings in SEC EDGAR's recent list, going back to Dec 6, 2005. Its latest annual report, Form ARS, was filed on Apr 23, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 14, 2026 (results of operations). The company's fiscal year ends on December 31.

Tvardi Therapeutics, Inc. SEC filings
Form Description Filed Period
ARS Annual report to shareholders Apr 23, 2026 Dec 31, 2025
10-K Annual report Mar 31, 2026 Dec 31, 2025
10-K Annual report Mar 11, 2025 Dec 31, 2024
ARS Annual report to shareholders Apr 22, 2024 Dec 31, 2023
10-K Annual report Mar 6, 2024 Dec 31, 2023
ARS Annual report to shareholders Apr 20, 2023 Dec 31, 2022
10-K Annual report Mar 6, 2023 Dec 31, 2022
10-K Annual report Mar 1, 2022 Dec 31, 2021
10-K Annual report Feb 25, 2021 Dec 31, 2020
10-K Annual report Feb 27, 2020 Dec 31, 2019
10-K Annual report Mar 12, 2019 Dec 31, 2018
10-K Annual report Mar 15, 2018 Dec 31, 2017
10-K Annual report Mar 10, 2017 Dec 31, 2016
10-K Annual report Mar 11, 2016 Dec 31, 2015
10-K Annual report Mar 27, 2015 Dec 31, 2014
10-K Annual report Mar 28, 2014 Dec 31, 2013

Showing 16 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
TVRD (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Sugar Land, TX
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1346830
Former names
Cara Therapeutics, Inc. (until Apr 11, 2025); Cara Therapeutics Inc (until Jul 21, 2010)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.